Five-year results from the randomized REDUCE trial show a continued benefit of patent foramen ovale (PFO) closure compared with antiplatelet therapy alone for the prevention of cryptogenic stroke.

A call has been made for a new classification of ischemic stroke for patients who have a patent foramen ovale (PFO) that is thought to have been the likely cause of the stroke. The new classification ...

Please provide your email address to receive an email when new articles are posted on . A new classification system accurately predicted which patients with ischemic stroke of unknown original might ...

It has been well established that device closure has, on average, prevented stroke recurrence in people who’ve had patent foramen ovale–associated stroke, but a meta-analysis has drilled down into ...

A patent foramen ovale (PFO) is a hole in the heart that doesn’t close as expected after birth. Before a baby is born, they have a hole between the left and right sides of their heart. This hole, ...

It's true that the older you get, the higher your risk of stroke increases. But strokes can occur at any age, even if you're "young" (that is, someone younger than 60). Often, strokes in the young are ...

Dan Kenny first started feeling a little off at the end of an otherwise normal workday in February 2023. "I kept telling myself, I'm going on this big trip, maybe I'm just a little tired and hadn't ...

Whether closure of a patent foramen ovale reduces the risk of recurrence of ischemic stroke in patients who have had a cryptogenic ischemic stroke is unknown. In a multicenter, randomized, open-label ...

Strokes that occur in patients with diagnosed patent foramen ovale (PFO) should no longer be deemed “cryptogenic” but rather “PFO-associated,” according to a new statement compiled by a team of both ...

Among adults ages 18-49 (median age of 41 years) who were born with a hole in the upper chambers of their heart known as patent foramen ovale (PFO), strokes of unknown cause were more strongly ...